Medela Rememdium Solutions, LLC – Trademark Portfolio
Entity Type: 16
Medela Rememdium Solutions, LLC holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 44 (Medical Services) — 2 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include MRS WELLNESS...EXPERIENCE THE DIFFERENCE. The owner is based in Chandler, AZ.
2940 South Cholla Street
Chandler, AZ 85286
Showing of trademarks Trademarks
Trademark Classifications
Medela Rememdium Solutions, LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Medela Rememdium Solutions, LLC have?
Medela Rememdium Solutions, LLC has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 abandoned.
What trademark classes does Medela Rememdium Solutions, LLC file in?
Medela Rememdium Solutions, LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 44 (Medical Services), Class 5 (Pharmaceuticals). Class 44 covers medical services; veterinary services; hygienic and beauty care for human beings or animals.
What are Medela Rememdium Solutions, LLC's most well-known trademarks?
Medela Rememdium Solutions, LLC's registered trademark portfolio includes well-known marks such as MRS WELLNESS...EXPERIENCE THE DIFFERENCE. These are among 1 currently registered trademark in the portfolio.
What is Medela Rememdium Solutions, LLC's trademark registration success rate?
Medela Rememdium Solutions, LLC has a 50% trademark registration rate, with 1 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.